The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 for ACL recovery: hype vs. science Adam C. Cady MHS, ATC, CSCS, PA C posted on the topic LinkedIn BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law How did BPC 157 become the wellness industry's star peptide?